197 related articles for article (PubMed ID: 22268042)
1. Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseases.
Kazakov SP; Zabotina TN; Korotkova OV; Dzabarov AK; Kazantseva IA
Bull Exp Biol Med; 2011 Feb; 150(4):453-8. PubMed ID: 22268042
[TBL] [Abstract][Full Text] [Related]
2. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
3. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases.
Xu WC; Chen SR; Huang JX; Zheng ZC; Chen LX; Lin JJ; Li YG
Eur J Histochem; 2007; 51(4):291-300. PubMed ID: 18162459
[TBL] [Abstract][Full Text] [Related]
4. [Expression of proliferation and apoptosis related genes in colorectal adenoma with malignant transformation].
Wang H; Yao H; Ding W; Yan L; Yu X
Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):405-8. PubMed ID: 11866939
[TBL] [Abstract][Full Text] [Related]
5. Detection of apoptotic cells and expression of Ki-67 antigen, Bcl-2, p53 oncoproteins in human parathyroid adenoma.
Wang W; Johansson H; Kvasnicka T; Farnebo LO; Grimelius L
APMIS; 1996 Nov; 104(11):789-96. PubMed ID: 8982242
[TBL] [Abstract][Full Text] [Related]
6. In situ apoptosis in the thyroid.
Sreelekha TT; Pradeep VM; Vijayalakshmi K; Belthazar A; Chellam VG; Nair MB; Pillai MR
Thyroid; 2000 Feb; 10(2):117-22. PubMed ID: 10718547
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue.
Hadar T; Shvero J; Yaniv E; Ram E; Shvili I; Koren R
Pathol Oncol Res; 2005; 11(1):45-9. PubMed ID: 15800682
[TBL] [Abstract][Full Text] [Related]
9. Potentialities of differential immunohistochemical diagnosis of some follicular tumors of the thyroid gland.
Poloz TL; Shkurupiy VA
Bull Exp Biol Med; 2008 Dec; 146(6):794-6. PubMed ID: 19513386
[TBL] [Abstract][Full Text] [Related]
10. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
[TBL] [Abstract][Full Text] [Related]
12. Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules.
Viacava P; Bocci G; Tonacchera M; Fanelli G; DeServi M; Agretti P; Berti E; Goletti O; Aretini P; Resta ML; Bevilacqua G; Naccarato AG
Thyroid; 2007 Mar; 17(3):191-7. PubMed ID: 17381350
[TBL] [Abstract][Full Text] [Related]
13. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.
Risso V; Lafont E; Le Gallo M
Cell Death Dis; 2022 Mar; 13(3):248. PubMed ID: 35301281
[TBL] [Abstract][Full Text] [Related]
15. [Cytofluorometric analysis of chosen markers of apoptosis CD95/CD95L (Fas/FasL) in thyroid tissues from young patients with Graves' disease and Hashimoto's thyroiditis].
Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Łyczkowska A; Niedziela M; Bardadin K; Czerwińska J; Dadan J; Baltaziak M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):83-90. PubMed ID: 16813711
[TBL] [Abstract][Full Text] [Related]
16. Expression and distribution of S-100, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in tissues of thyroid carcinoma.
Xu W; Li X; Chen S; Huang J; Lin S; Lin J; Li Y; Tan X
Eur J Histochem; 2008; 52(3):153-62. PubMed ID: 18840555
[TBL] [Abstract][Full Text] [Related]
17. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
19. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins.
Stassi G; Di Liberto D; Todaro M; Zeuner A; Ricci-Vitiani L; Stoppacciaro A; Ruco L; Farina F; Zummo G; De Maria R
Nat Immunol; 2000 Dec; 1(6):483-8. PubMed ID: 11101869
[TBL] [Abstract][Full Text] [Related]
20. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
Farid P; Gomb SZ; Péter I; Szende B
Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]